Related Experiment Video
Updated: Feb 25, 2026
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
A computational phenotype for difficult-to-treat asthma with corticosteroid overuse using electronic health care
Nikki C C Werkman1, Angelique Egberts1, Youssra Bais1
1Department of Clinical Pharmacy, Franciscus, Rotterdam and Schiedam, The Netherlands.
Background:
Patients with difficult-to-treat asthma experience insufficient symptom control despite intensive treatment, leading to overuse of oral corticosteroids (OCSs), which is associated with high patient and economic burden. Many of these remain unnoticed, even by their pulmonologist.
Objective:
We sought to create a query, also known as computational phenotype, identifying patients with difficult-to-treat asthma to facilitate their access to treatment optimalization.
Methods:
We used electronic health care records from 2 Dutch hospitals: Franciscus and Admiraal de Ruyter Hospital (Adrz) from the year 2023. We included adult patients with at least 1 hospital visit for asthma. The query was built using Structured Query Language code with data from Franciscus and subsequently applied to data in Franciscus and Adrz. Performance was scored by manual evaluation of the patient records by a pulmonologist and a pharmacist.
Results:
We included 1217 (Franciscus) and 267 (Adrz) patients. The query classified patients as having difficult-to-treat asthma when they had used high-dose inhaled corticosteroids during at least 90 days and had either received at least 2 courses of high-dose OCSs, or at least 90 days of low-dose OCSs in 2023. The sensitivity, specificity, positive predictive value, and negative predictive value were 0.75, 0.76, 0.63, and 0.85 in Franciscus, and 0.40, 0.95, 0.80, and 0.78 in Adrz, respectively.
Conclusions:
The query is an efficient way of identifying patients with difficult-to-treat asthma and OCS overuse.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...